Page
Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.
Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…
Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…
View ReportThe 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…
View ReportThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreThis report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…
Read MoreEUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH ANNUAL MEETING (ESDR) | LISBON, PORTUGAL Program chairs: Johann…
EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY (EADV) | AMSTERDAM, NETHERLANDS Program chairs: Lone Skov, Denmark and…
The spread of COVID-19 in early 2020 brought many concerns and questions about COVID-19 and psoriasis. To help address…
Read MoreIn the final webinar in the series, we will explore lessons from the SARS-CoV-2 pandemic and how we can prepare for…
Watch VideoWatch Video
The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world…
Read MoreThe ESDR congress included many noteworthy psoriasis presentations from both IPC councilors and experts from around the…
Read MoreSatveer Mahil joins the group of respected IPC psoriasis experts who are working to advance knowledge and enhance the…
Read MoreHeld virtually on December 11 due to the Coronavirus Pandemic, the 2020 IPC Think Tank convened more than 100…
Read MoreThe registries, PsoProtect and PsoProtectMe, aim to help health care workers understand how the novel virus affects…
Read MoreView Report
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.